{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T04:40:08Z","timestamp":1728103208369},"reference-count":13,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,9,30]]},"DOI":"10.1536\/ihj.24-444","type":"journal-article","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T22:14:26Z","timestamp":1727648066000},"page":"789-791","source":"Crossref","is-referenced-by-count":0,"title":["Is Isolated Cardiac Sarcoidosis an Independent Disease Entity with Poor Prognosis in Sarcoidosis Cases?"],"prefix":"10.1536","volume":"65","author":[{"given":"Masae","family":"Uehara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Onco-Cardiology\/Cardiovascular Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mactaggart S, Ahmed R. Comparison of prognosis in isolated versus systemic manifestations of cardiac sarcoidosis. Curr Probl Cardiol 2024; 49: 102671.","DOI":"10.1016\/j.cpcardiol.2024.102671"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Terasaki F, Azuma A, Anzai T, <i>et al<\/i>. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version. Circ J 2019; 83: 2329-88.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Masunaga T, Hashimoto T, Fujino T, <i>et al<\/i>. Different impact of immunosuppressive therapy on cardiac outcomes in systemic versus isolates cardiac sarcoidosis. Int Heart J 2024; 65: 856-65.","DOI":"10.1536\/ihj.24-166"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Okada T, Kawaguchi N, Miyagawa M, <i>et al<\/i>. Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET\/CT. J Nucl Cardiol 2023; 30: 280-9.","DOI":"10.1007\/s12350-022-03034-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takaya Y, Nakamura K, Nishii N, Ito H. Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria. Int J Cardiol 2021; 345: 49-53.","DOI":"10.1016\/j.ijcard.2021.10.150"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sato K, Kawamatsu N, Yamamoto M, Machino-Ohtsuka T, Ishizu T, Ieda M. Utility of updated Japanese Circulation Society guidelines to diagnose isolated cardiac sarcoidosis. J Am Heart Assoc 2022; 11: e025565.","DOI":"10.1161\/JAHA.122.025565"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Kandolin R, Lehtonen J, Airaksinen J, <i>et al<\/i>. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015; 131: 624-32.","DOI":"10.1161\/CIRCULATIONAHA.114.011522"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sink J, Joyce C, Liebo MJ, Wilber DJ. Long-term outcomes of cardiac sarcoid: prognostic implications of isolated cardiac involvement and impact of diagnostic delays. J Am Heart Assoc 2023; 12: e028342.","DOI":"10.1161\/JAHA.122.028342"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tezuka D, Terashima M, Kato Y, <i>et al<\/i>. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography\/computerized tomography. J Card Fail 2015; 21: 313-22.","DOI":"10.1016\/j.cardfail.2014.12.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Maeda D, Matsue Y, Dotare T, <i>et al<\/i>. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: insights from the ILLUMINATE-CS study. Eur J Heart Fail 2024; 26: 77-86.","DOI":"10.1002\/ejhf.3056"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Okada DR, Bravo PE, Vita T, <i>et al<\/i>. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol 2018; 25: 1136-46.","DOI":"10.1007\/s12350-016-0658-1"},{"key":"12","unstructured":"12. Ahmed R, Sawatari H, Amanullah K, <i>et al<\/i>. Characteristics and outcomes of hospitalized patients with heart failure and sarcoidosis: A propensity-matched analysis of the nationwide readmissions database 2010-2019. Am J Med 2024. S0002-9343(24)00206-7."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chiu CZ, Nakatani S, Zhang G, <i>et al<\/i>. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-6.","DOI":"10.1016\/j.amjcard.2004.08.083"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/5\/65_24-444\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T04:11:26Z","timestamp":1728101486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/5\/65_24-444\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-444","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"article-number":"24-444"}}